2 months ago
MBX
AnalystsEliana MerleEliana Merle's Stock Forecasts
AnalystsEliana Merle
Sectors:
Industries:
Analyst Ranking
Top 11%
#576 out of 5315 analysts
Average Return
+14.17%
Win Rate
56%60 out of 108
Risk vs Reward
Poor
Good
Eliana Merle's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Iveric Bio IncISEE | +237.97% | $11.01 | $37.21 | 2022-08-02 - 2023-05-03 | Strong Buy |
Cymabay Therapeutics IncCBAY | +213.84% | $1.59 | $4.99 | 2020-03-13 - 2021-03-12 | Strong Buy |
Kymera Therapeutics IncKYMR | +168.30% | $31.14 | $83.55 | 2025-05-13 - 2026-05-12 | Strong Buy |
Cymabay Therapeutics IncCBAY | +166.61% | $12.07 | $32.18 | 2023-08-14 - 2024-02-14 | Strong Buy |
Kadmon Holdings IncKDMN | +148.04% | $3.83 | $9.50 | 2021-05-21 - 2021-11-09 | Strong Buy |
Eliana Merle Analyst Color
Get additional color on Eliana Merle's coverage of popular stocks
2 months ago
ASND
3 months ago
INSM
3 months ago
IONS
4 months ago
BMRN
5 months ago
KYMR
5 months ago
VRTX
5 months ago
PTCT
10 months ago
BBIO
10 months ago
GOSS
a year ago
ALNY
a year ago
PROK
a year ago
BMRN
a year ago
ETNB
a year ago
AKRO
a year ago
RVMD
2 years ago
BMRN
2 years ago
MRNA
2 years ago
APLS
3 years ago
CBAY
3 years ago
APLS
4 years ago
MRNA
Eliana Merle's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sab Biotherapeutics IncSABS | 1 | Strong Buy | $13.00 | +233.33% | Initiates Coverage On | 14 days ago |
Uniqure NvQURE | 7 | Strong Buy | $65.00 | +56.97% | Upgrades | 20 days ago |
Gossamer Bio IncGOSS | 6 | Strong Sell | $0.28 | +58.19% | Maintains | 2 months ago |
Mbx Biosciences IncMBX | 2 | Strong Buy | $70.00 | +12.90% | Maintains | 2 months ago |
Ascendis Pharma AASND | 4 | Strong Buy | $345.00 | +29.23% | Maintains | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 3 | Strong Buy | $615.00 | +17.76% | Maintains | 2 months ago |
Moderna IncMRNA | 11 | Hold | $45.00 | -43.59% | Maintains | 2 months ago |
Regeneron Pharmaceuticals IncREGN | 2 | Strong Buy | $917.00 | +35.60% | Maintains | 2 months ago |
Ionis Pharmaceuticals IncIONS | 2 | Strong Buy | $115.00 | +33.23% | Maintains | 2 months ago |
Ultragenyx Pharmaceutical IncRARE | 1 | Strong Buy | $43.00 | +19.88% | Maintains | 2 months ago |
Insmed IncINSM | 2 | Strong Buy | $237.00 | +110.03% | Maintains | 3 months ago |
Apellis Pharmaceuticals IncAPLS | 9 | Hold | $41.00 | -0.07% | Maintains | 3 months ago |
Biomarin Pharmaceutical IncBMRN | 4 | Strong Buy | $105.00 | +73.99% | Maintains | 4 months ago |
Tpg IncTPG | 2 | Strong Buy | $56.00 | +32.01% | Maintains | 4 months ago |
Kymera Therapeutics IncKYMR | 4 | Strong Buy | $133.00 | +11.54% | Maintains | 5 months ago |
Tyra Biosciences IncTYRA | 2 | Strong Buy | $59.00 | +84.72% | Initiates Coverage On | 5 months ago |
Sagimet Biosciences IncSGMT | 2 | Hold | $8.00 | +4.03% | Initiates Coverage On | 5 months ago |
Ptc Therapeutics IncPTCT | 1 | Strong Buy | $119.00 | +33.41% | Upgrades | 5 months ago |
Madrigal Pharmaceuticals IncMDGL | 6 | Strong Buy | $964.00 | +76.76% | Initiates Coverage On | 5 months ago |
Inventiva SaIVA | 2 | Strong Buy | $18.00 | +294.74% | Initiates Coverage On | 5 months ago |
4d Molecular Therapeutics IncFDMT | 1 | Strong Buy | $33.00 | +157.41% | Initiates Coverage On | 5 months ago |
Bridgebio Pharma IncBBIO | 5 | Strong Buy | $80.00 | +2.68% | Initiates Coverage On | 5 months ago |
Alnylam Pharmaceuticals IncALNY | 4 | Strong Buy | $527.00 | +63.87% | Initiates Coverage On | 5 months ago |
Altimmune IncALT | 2 | Strong Buy | $24.00 | +694.70% | Maintains | a year ago |
Rapt Therapeutics IncRAPT | 4 | Hold | $9.00 | -84.49% | Maintains | a year ago |
Anaptysbio IncANAB | 5 | Hold | $20.00 | -70.29% | Maintains | a year ago |
Sarepta Therapeutics IncSRPT | 1 | Hold | $12.00 | -39.36% | Downgrades | a year ago |
Prokidney CorpPROK | 1 | Strong Buy | $8.00 | +310.26% | Maintains | a year ago |
Curevac NvCVAC | 3 | Hold | $5.50 | N/A | Downgrades | a year ago |
Arvinas IncARVN | 5 | Strong Buy | $21.00 | N/A | Maintains | a year ago |
89bio IncETNB | 3 | Strong Buy | $38.00 | N/A | Maintains | a year ago |
Akero Therapeutics IncAKRO | 4 | Strong Buy | $109.00 | N/A | Maintains | a year ago |
Zentalis Pharmaceuticals IncZNTL | 4 | Hold | $2.20 | N/A | Maintains | a year ago |
Revolution Medicines IncRVMD | 2 | Strong Buy | $71.00 | N/A | Maintains | a year ago |
Biontech SeBNTX | 4 | Hold | $131.00 | N/A | Maintains | 2 years ago |
Kodiak Sciences IncKOD | 3 | Hold | $5.00 | N/A | Maintains | 2 years ago |
Terns Pharmaceuticals IncTERN | 2 | Strong Buy | $18.00 | N/A | Maintains | 2 years ago |
Cymabay Therapeutics IncCBAY | 5 | Hold | $32.50 | N/A | Downgrades | 2 years ago |
Iveric Bio IncISEE | 2 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Monte Rosa Therapeutics IncGLUE | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 4 years ago |
Regenxbio IncRGNX | 1 | Strong Buy | $47.00 | N/A | Maintains | 4 years ago |
Kadmon Holdings IncKDMN | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 5 years ago |
Amicus Therapeutics IncFOLD | 2 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 5 years ago |
Lakefront Biotherapeutics NvLKFT | 2 | Hold | $134.00 | N/A | Maintains | 6 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Hold | $121.00 | N/A | Initiates Coverage On | 6 years ago |
Cartesian Therapeutics IncRNAC | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 6 years ago |
Tesaro IncTSRO | 1 | Strong Buy | $68.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.